On the HCPLive irritable bowel syndrome page, resources on the topics of medical news and expert insight into IBS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBS, IBD, and more.
April 19th 2024
In recognition of World IBS Day, we spoke with Jeffrey Roberts about what led him to found the holiday in 2019 and took a closer look at the continued marginalization of the condition.
Effective Management of Fecal Incontinence Requires Thorough Physical Exam, History
January 19th 2014Clinicians should be familiar with all current testing options and assessment tools and be prepared to offer support and guidance to patients who may be embarrassed or unwilling to discuss this aspect of their health.
In the Future, IBD Treatment Will Focus on More Cost-Effective, Quality Care
January 18th 2014With renewed attention on maximizing return on every dollar spent on health care, gastroenterologists need to take a thoughtful approach that takes cost and the overall patient experience into account when they make testing and treatment decisions with patients who have inflammatory bowel disease.
EMR Analysis Reveals Significant Predictors of Fibromyalgia Diagnosis
Noting that it takes an average of 5 years before a fibromyalgia patient receives a diagnosis, researchers conducted a retrospective data analysis to identify significant variables that may enable earlier detection and diagnosis of fibromyalgia.
Anxiety-Depression Disorder Aggravates Digestive Symptoms in IBS Patients
In a study published in Experimental and Therapeutic Medicine, a professor in the Department of Digestive System at Xingtai People's Hospital in China, investigated the correlation between psychological status and the mechanism of action of pro-inflammatory and anti-inflammatory cytokines in patients with diarrhea-predominant irritable bowel syndrome (IBS-D).
Ramosetron Shows Long-Term Efficacy in IBS-D without Alosetron's Adverse Side Effects
In a clinical review published in Clinical and Experimental Gastroenterology, researchers from Iwate Medical University in Japan evaluated the long-term safety and efficacy of the novel serotonin-receptor agonist ramosetron in patients suffering from diarrhea-predominant irritable bowel syndrome (IBS-D).
Study Finds Physicians Ignore Behavioral Therapy Referral Standards for IBS Management
Recognizing frustrations stemming from "the contested nature of the diagnosis, ineffective treatments, and a mismatch between general practitioner (GP) and patient explanatory models" for irritable bowel syndrome, a team of British researchers examined the tensions between how physicians approach IBS and what's currently recommended for diagnosing and managing the functional gastrointestinal disorder.
Researchers Test Correlation between IBS Symptoms and Methane, Hydrogen Gas Concentrations
Researchers at the Hanyang University College of Medicine set the record straight on the association between IBS symptoms and methane and hydrogen gas produced by intestinal fermentation of lactulose and excreted in the breath during lactulose breath test.
Postmenopausal Women with IBS-C Benefit from Melatonin More than IBS-D Counterparts
Recognizing that melatonin secretion from the gastrointestinal (GI) tract improves abdominal pain in irritable bowel syndrome (IBS) but decreases with age, Polish researchers from the Medical University of Lodz aimed to define the effect of administering melatonin in postmenopausal women with different predominating IBS symptoms.
Researcher Sorts Through Sea of IBS Remedies
May 22nd 2013As irritable bowel syndrome (IBS) remains a complicated condition to treat with an etiology that's still unknown, it's difficult for physicians to find the best proven therapies among new remedies and the variety of pharmacological and nondrug options they have been trying for years.
Abdominal, Bowel Symptom Improvement From Linaclotide Meets FDA Standards for IBS-C
May 21st 2013Patients taking linaclotide experience clinically meaningful improvement in abdominal and bowel symptoms, which closely correlate with the US Food and Drug Administration's new criteria for irritable bowel syndrome with constipation (IBS-C).
Identifying Symptoms of Irritable Bowel Syndrome in Patients with Inflammatory Bowel Disease
May 15th 2013Patients who have IBD, even those who are in clinical remission, often exhibit symptoms consistent with IBS, which can complicate the assessment and management of IBD and lead to unnecessary interventions.
The Role of Stigma in Irritable Bowel Syndrome
April 21st 2013The stigma attached to chronic diseases such as IBS has been shown to negatively affect patients' self-image and sense of worth, leading to worse outcomes. Being aware of this and working to counteract the psychological effects of stigma can improve the patient-physician relationship and lead to better outcomes.